ACYCLOVIR OTC SWITCH REVIEW PUT OFF

WASHINGTON (FNS) -- Two advisory committees to the Food and Drug Administration have postponed a review of whether acyclovir should be switched from prescription to over-the-counter for treating genital herpes.The committees were scheduled to meet on July 28. However, acyclovir's manufacturer, Burroughs Wellcome, Research Triangle Park, N.C., has requested more time to submit data. Once the advisory

WASHINGTON (FNS) -- Two advisory committees to the Food and Drug Administration have postponed a review of whether acyclovir should be switched from prescription to over-the-counter for treating genital herpes.

The committees were scheduled to meet on July 28. However, acyclovir's manufacturer, Burroughs Wellcome, Research Triangle Park, N.C., has requested more time to submit data. Once the advisory committees make their recommendation, it's up to the FDA to accept or reject it.

Register to view the full article

Already a member? .